Cambridge Isotope Laboratories, Inc.
Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. CIL’s core expertise lies in replacing common atoms such as ¹H, ¹²C, ¹⁴N, and ¹⁶O with rare, non-radioactive isotopes like ²H (Deuterium), ¹³C, ¹⁵N, and ¹⁸O, enabling a wide range of scientific and technological applications.
CIL’s portfolio of over 11,000 products supports key areas of research and industry. In life sciences and medical diagnostics, isotope-labeled standards such as amino acids and fatty acids are used in metabolomics and proteomics to quantify metabolites and proteins, advancing biomarker discovery in cancer, Alzheimer’s, and diabetes research. In drug development, stable isotopes serve as tracers in metabolic studies to determine drug pathways and kinetics, with cGMP-grade materials available for clinical trials. For clinical diagnostics, compounds like ¹³C urea are used in non-invasive breath tests, for example in detecting H. pylori infections.
Beyond healthcare, CIL products contribute to environmental analysis, electronics, quantum applications, and structural biology, including specialized media and reagents for biomolecular NMR studies. The company also offers custom synthesis and mixtures, backed by rigorous quality systems such as ISO 13485 accreditation.
